Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 92801-92850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05045482
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
PHASE1Recruiting
30 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05050266
Enhancing Mental and Physical Health of Women Veterans
NAActive, not recruiting
20 participants
Started: Oct 21, 2021 · Completed: Sep 30, 2026
14 conditions1 sponsor1 location
NCT05007873
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
PHASE2Recruiting
70 participants
Started: Oct 21, 2021 · Completed: Oct 30, 2026
4 conditions3 sponsors1 location
NCT04327115
Study of an Physical Exercise Program on Older People of 75 Years Old and More, Hospitalized in Geriatric Short Stay
NARecruiting
864 participants
Started: Oct 21, 2021 · Completed: Dec 20, 2025
2 conditions1 sponsor1 location
NCT05092165
Methylene Blue for the Prevention of Hypotension During Hemodialysis
PHASE2Recruiting
260 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05078190
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
N/AActive, not recruiting
200 participants
Started: Oct 21, 2021 · Completed: Oct 31, 2039
4 conditions2 sponsors1 location
NCT05011071
The Alberta BLOOM Premature Child Study
N/AEnrolling by invitation
535 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2027
6 conditions3 sponsors1 location
NCT05518864
GAG-therapy Efficacy Trial Solution for Bladder Pain Syndrome/ Interstitial Cystitis (GETSBI Study)
PHASE4Recruiting
80 participants
Started: Oct 21, 2021 · Completed: Oct 21, 2024
1 condition5 sponsors8 locations
NCT05212350
Total pancrEaTectomy vs High-Risk Pancreatic anastomosiS
NARecruiting
98 participants
Started: Oct 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT04514497
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
PHASE1Active, not recruiting
28 participants
Started: Oct 20, 2021 · Completed: Mar 4, 2026
12 conditions1 sponsor23 locations
NCT05121038
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Oct 20, 2021 · Completed: Sep 30, 2026
3 conditions2 sponsors3 locations
NCT05073848
Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors
N/ARecruiting
150 participants
Started: Oct 20, 2021 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT05000983
A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
PHASE1/PHASE2Recruiting
25 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05365893
PHL Treatment in Pancreatic Cancer
EARLY_PHASE1Recruiting
20 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04598399
Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
NARecruiting
168 participants
Started: Oct 20, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor7 locations
NCT05102760
PENG vs. FIC Block for Hip Fracture ED Patients
NAActive, not recruiting
80 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05051735
PARASTOP - Paracetamol With Strong Opioids
PHASE3Recruiting
204 participants
Started: Oct 20, 2021 · Completed: Jan 31, 2026
2 conditions2 sponsors15 locations
NCT04923620
Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
N/ARecruiting
51 participants
Started: Oct 20, 2021 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT05091541
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2Not yet recruiting
125 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2039
1 condition1 sponsor0 locations
NCT06620601
Digital Technology for Sleep and Homelessness
NARecruiting
100 participants
Started: Oct 20, 2021 · Completed: Oct 31, 2025
4 conditions1 sponsor2 locations
NCT04646395
Study of Acalabrutinib and Tafasitamab in MZL Patients
PHASE2Active, not recruiting
26 participants
Started: Oct 20, 2021 · Completed: Mar 15, 2028
1 condition1 sponsor9 locations
NCT05082454
Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)
N/AActive, not recruiting
108 participants
Started: Oct 20, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor11 locations
NCT06814392
Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
N/AActive, not recruiting
1,600 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05198674
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NAActive, not recruiting
1,300 participants
Started: Oct 20, 2021 · Completed: Nov 30, 2029
5 conditions1 sponsor100 locations
NCT05057468
Second-line Treatment of Primary Autoimmune Hemolytic Anemia
PHASE3Recruiting
30 participants
Started: Oct 20, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor2 locations
NCT04852965
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors
N/AActive, not recruiting
103 participants
Started: Oct 20, 2021 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05101096
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
135 participants
Started: Oct 20, 2021 · Completed: May 31, 2026
4 conditions1 sponsor36 locations
NCT05077748
An 18-year Follow-up Study on OSA in a Population-based Cohort
N/ARecruiting
248 participants
Started: Oct 20, 2021 · Completed: Sep 30, 2025
5 conditions2 sponsors1 location
NCT05025878
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
N/ARecruiting
10 participants
Started: Oct 20, 2021 · Completed: Aug 31, 2024
2 conditions4 sponsors1 location
NCT04891809
Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM
PHASE2Active, not recruiting
198 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2028
1 condition6 sponsors14 locations
NCT04748861
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
NAActive, not recruiting
150 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2026
3 conditions4 sponsors1 location
NCT04014348
Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women
N/ARecruiting
250 participants
Started: Oct 20, 2021 · Completed: Dec 26, 2025
1 condition1 sponsor1 location
NCT05115292
A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma
PHASE1Active, not recruiting
85 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2025
1 condition1 sponsor6 locations
NCT04955899
Safety of Splenic Stimulation for RA
NARecruiting
5 participants
Started: Oct 20, 2021 · Completed: Apr 30, 2029
1 condition2 sponsors2 locations
NCT05131659
Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD
NAActive, not recruiting
64 participants
Started: Oct 20, 2021 · Completed: May 31, 2026
3 conditions3 sponsors2 locations
NCT04486352
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
PHASE1/PHASE2Recruiting
148 participants
Started: Oct 20, 2021 · Completed: Oct 31, 2027
1 condition5 sponsors21 locations
NCT05000840
Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA
N/AActive, not recruiting
750 participants
Started: Oct 20, 2021 · Completed: Mar 31, 2025
2 conditions3 sponsors1 location
NCT05044897
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
PHASE2Active, not recruiting
11 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05984628
Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds
NARecruiting
88 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2026
2 conditions1 sponsor1 location
NCT05121519
Does Eliminating Coffee Avoid Fibrillation?
NAActive, not recruiting
200 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2025
2 conditions1 sponsor3 locations
NCT05044143
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
N/ARecruiting
303 participants
Started: Oct 20, 2021 · Completed: Dec 20, 2025
1 condition1 sponsor6 locations
NCT05009992
Combination Therapy for the Treatment of Diffuse Midline Gliomas
PHASE2Recruiting
360 participants
Started: Oct 20, 2021 · Completed: Jun 30, 2029
6 conditions5 sponsors32 locations
NCT05118828
Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial
NAActive, not recruiting
1,000 participants
Started: Oct 20, 2021 · Completed: Jun 30, 2026
2 conditions6 sponsors6 locations
NCT05122039
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
N/ARecruiting
200 participants
Started: Oct 20, 2021 · Completed: Oct 19, 2032
1 condition1 sponsor1 location
NCT04697576
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
PHASE1Recruiting
36 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2026
9 conditions1 sponsor1 location
NCT05974826
Healthy Communities: a Healthy City Preventive Program on Cardiovascular Health and Well-being (HC)
NAActive, not recruiting
2,000 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2030
3 conditions3 sponsors1 location
NCT04629144
Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)
PHASE2Recruiting
48 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2025
2 conditions1 sponsor20 locations
NCT04927689
Evaluation of an Environmental Counsellor's Home Stay in Children Treated for Asthma or Allergic Rhinitis Via a Standardized Medical Questionnaire Randomized Controlled Superiority Trial in Parallel Arms, Multicentric (EvalPCE)
N/AActive, not recruiting
100 participants
Started: Oct 20, 2021 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT05500846
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial
NAActive, not recruiting
51 participants
Started: Oct 19, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT05516810
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
N/AActive, not recruiting
500 participants
Started: Oct 19, 2021 · Completed: Sep 30, 2024
5 conditions2 sponsors2 locations